. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci, and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect.
Introduction
Streptococcus pyogenes (Group A streptococci) is the most common cause of bacterial pharyngitis. The organism is also frequently isolated in skin and skin-structure infections. Penicillin is generally considered the drug of choice for treatment of pharyngitis and other non-invasive streptococcal infections, with macrolides recommended as alternative agents in penicillin-allergic patients. 1 While S. pyogenes remains uniformly susceptible to penicillin, there have been reports of increasing erythromycin resistance over the past decade. 2 The ketolides, semisynthetic 14-membered ring macrolides, represent a new subclass of agents among the macrolide-lincosamide-streptogramin group. One of the newest agents, ABT-773, has demonstrated excellent in vitro activity against both erythromycin-susceptible and -resistant strains of S. pyogenes. 3 While the MIC data look very promising, additional information is needed on the time-kill kinetics of these new agents. The purpose of this study was to compare the bactericidal activity of ABT-773 and amoxicillin against S. pyogenes in vitro.
Materials and methods
MIC and time-kill assays were performed on 10 clinical isolates of S. pyogenes (six erythromycin susceptible and four erythromycin resistant). The erythromycin-susceptible strains were isolated from patients at the University of Illinois at Chicago Medical Center (Chicago, IL, USA). Erythromycin-resistant strains (two mefA and two ermTR) were kindly provided by Drs Michael Jacobs and Elizabeth Palavecino (Case Western Reserve University, Cleveland, OH, USA). The erythromycin-resistant isolates had been collected from patients at University hospitals in Cleveland. The control strain, S. pneumoniae ATCC 49619, was used for validation of MIC results.
ABT-773 (Abbott Laboratories, Abbott Park, IL, USA), amoxicillin and erythromycin (United States Pharmacopeia, Rockville, MD, USA) powders were prepared according to NCCLS guidelines or manufacturer's recommendations. 4 Cation-supplemented Mueller-Hinton broth with 3% lysed horse blood (Remel, Lenexa, KS, USA) was the medium used for the MIC and time-kill assays. MICs were performed in duplicate following NCCLS guidelines using the broth microdilution method. 4 The bactericidal activity of the antimicrobial agents was determined in duplicate using the time-kill method following NCCLS guidelines. 5 Antimicrobial concentrations tested were 2 ϫ and 8 ϫ MIC. Sampling for colony counts was performed at 0, 2, 6 and 24 h. Antibiotic carryover was prevented by saline dilutions. Viable counts were determined after 24 h of incubation at 35ЊC with 5% CO 2 . The rate and extent of killing were determined by plotting colony counts (log 10 cfu/mL) against time (h). Bactericidal activity was defined as a у3 log 10 decrease in cfu/mL, while bacteriostatic activity was defined as a Ͻ3 log 10 decrease in cfu/mL. The lower limit of detection was 1.3 log 10 cfu/mL.
Results and discussion
Independently of erythromycin susceptibility, both ABT-773 and amoxicillin were highly active against all S. pyogenes isolates. The MIC ranges (mg/L) were 0.004-0.25 of ABT-773 and 0.015-0.12 of amoxicillin. Based upon the proposed breakpoints for ABT-773 against nonpneumococcal Streptococcus spp. (р0.5 mg/L for susceptible, 1 mg/L for intermediate and у2 mg/L for resistant), the 10 strains would be considered susceptible. 6 The results of the time-kill experiments are given in Figures 1 and 2 . At 24 h, ABT-773 8 ϫ MIC demonstrated bactericidal activity against six strains (four erythromycin susceptible and two containing the mefA gene). Bactericidal activity was observed at 24 h against three strains at an ABT-773 concentration of 2 ϫ MIC (one erythromycin susceptible and two containing the mefA gene). In comparison, amoxicillin at concentrations of 2 ϫ and 8 ϫ MIC was bactericidal against all 10 isolates at 24 h. Both the rate and extent of killing were less for ABT-773 than amoxicillin against the 10 isolates. Limited data are available on the time-kill kinetics of ketolides against S. pyogenes. 7, 8 Odenholt et al. 7 studied the bactericidal activity of telithromycin against one erythromycin-susceptible and two erythromycin-resistant strains. Similar to our results, the authors noted a slow rate of killing (Ͻ2 log 10 cfu/mL after 12 h) against the three isolates. The telithromycin concentration (0.6 mg/L) utilized in their study was reported to correspond to a 2 h free, unbound serum level following a 800 mg dose. Boswell et al.
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8 also performed time-kill studies with telithromycin against three isolates of S. pyogenes. At concentrations of 10 ϫ MIC, bactericidal activity was reported with telithromycin in 2/3 strains at 24 h. Similar results were obtained in our study with 8 ϫ MIC ABT-773. Organisms exposed to concentrations of telithromycin 2 ϫ MIC demonstrated increased growth (1.51-4.17 log 10 cfu/mL), whereas in our study, ABT-773 2 ϫ MIC demonstrated bacteriostatic activity against seven isolates and bactericidal activity against three isolates.
In conclusion, ABT-773 demonstrated in vitro activity against both erythromycin-susceptible and -resistant strains of S. pyogenes. Further in vitro and in vivo studies are needed to define further the role of ABT-773 in infections due to S. pyogenes. 
